Concurrent Oral Session 1: Transplant Oncology
Thursday, May 7, 2026, 11:15 AM - 12:30 PM

Moderated by: Chi Leung Chiang & Sherrie Bhoori

 

Liver Transplantation for Portal Vein Tumor Thrombus in the Immunotherapy Era: Outcomes and Risk Stratification in a Multi-Institutional Study
Rebecca Marino

Post-Curative ctDNA Monitoring in Colorectal Liver Metastases Treated by Partial Hepatic Resection or Transplant
Abigail Loszko

Alpha‑Adrenergic Neuro-Immune Signaling Impacts Cancer Recurrence After Liver Transplantation
Yuanjin Lyu

Steatotic Grafts Synergize with Cold Ischemia Injury to Increase the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
Wenzhi Shu

External Validation and Clinical Utility of the TRAIN-AI Model for Predicting Post-Transplant Recurrence of Hepatocellular Carcinoma
Quirino Lai

Impact of Hierarchy in Locoregional Therapy in Liver Transplantation for Hepatocellular Carcinoma: A 24-Year Monocentric Analysis
Enrico Prosperi

Six-Month Sustained Disease Control Selects HCC Patients Beyond the Milan Criteria for Liver Transplant with Comparable Oncologic Outcomes: An International Multicenter Cohort Study (TORCH-2401)
Kunlin Xie